Latest Global Expansion News

Takeover chatter lit up Pepper Money, while Identitii ran hard after a regulator stepped in. At the other end, AMP slid despite higher profit, as investors weighed leadership change and legal costs.

iCandy Interactive’s subsidiary Lemon Sky Studios has appointed a seasoned industry leader to drive global partnerships, secured over A$1 million in recent contracts, and is exploring strategic options to unlock shareholder value.

Humm Group Limited reported a $13.9 million statutory profit for the half-year ended December 2025, despite increased credit losses and elevated costs. The company’s ongoing transformation and global expansion underpin cautious optimism for the year ahead.

Ionic Rare Earths is advancing its rare earth magnet recycling ambitions with strategic leadership relocation, government recognition, and new funding discussions. The company’s Belfast facility gains global significance as it targets key international markets.

Kelly Partners Group Holdings Limited has reported a robust 17% increase in revenue for the first half of 2026, driven by strategic acquisitions and expanding international operations, particularly in the US.

Eden Innovations has appointed Dr Allan Godsk Larsen as Managing Director to spearhead its global growth, leveraging his deep expertise in carbon nanotube technology amid strong commercial momentum and significant debt reduction.

A volatile week for ASX tech saw a steep sell-off in freight software, while defence AI and RegTech contract wins pulled buyers back into smaller names. Big corporate actions kept attention on what’s real: signed deals, cash timelines, and who pays whom, and when.

GCM Corporation is advancing its commercialisation strategy with multiple prototypes across key global markets and sectors, aiming for revenue in the first half of 2026.

Genetic Signatures has appointed Maria Halasz as its new CEO, bringing over two decades of leadership in life sciences and capital markets to steer the company’s global expansion.

Orthocell Ltd reports steady progress in commercialising its nerve repair product Remplir in the US, with sales growth, expanded distributor networks, and manufacturing upgrades underpinning its path to profitability.

Small caps did the heavy lifting this week, led by two big discovery stories in resources. Funding raises and takeover moves kept attention on who can pay for the next step, not just promise it.

A handful of small caps ripped higher, but plenty still slipped even after good news. This week’s biggest moves came from a platform partnership win, a reinstated stock, and a cash settlement that removed a long-running dispute.